#drug design — Friday, July 17, 2026 (3 items)
| 0 | 💬 0 |
Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-07-17 | #antiviral #cyclophilins #respiratory #inhibitor #drug design | |
| 0 | 💬 0 |
N-terminally modified GLP1R agonists drive G protein bias via extracellular loop 3 displacement.
(linkinghub.elsevier.com)
|
Cell Reports 2026-07-17 | #gpcr #diabetes #signaling #drug design #structural biology | |
| 0 | 💬 0 |
The structures of ecteinascidin anticancer agents bound to DNA shed light on their mechanism of action.
(academic.oup.com)
|
Nucleic Acids Research 2026-07-17 | #anticancer #ecteinascidins #dna-binding #crystallography #drug design |